Product Information
TRI-LUMA CREAM is a brand product labeled by Galderma Laboratories, L.P., priced at $7.8336 per GM under NDC 00299595030. Its NADAC has been published 551 times since Nov 28, 2013.
FDA first approved this application on Jan 18, 2002.
Strength
.1; 40; .5 mg/g; mg/g; mg/g
Manufacturer
Galderma Laboratories, L.P.NDC
00299595030
Classification
Brand
Dosage Form
CREAM
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
FLUOCINOLONE ACETONIDE; HYDROQUINONE; TRETINOINApproval Type
New Drug (NDA)
FDA Application
NDA021112FDA Approved
1/18/2002
On Market Since
1/18/2002
Pharmacological Classes
Price Statistics
The NADAC for TRI-LUMA CREAM has been published 551 times since Nov 28, 2013, and over the history we have for it it has risen 143.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $7.8336 per GM |
|---|---|
| All-time high | $7.8635 (May 14, 2025) |
| All-time low | $3.2020 (Mar 23, 2016) |
| 52-week high | $7.8351 |
| 52-week low | $7.8225 |
| Median price | $6.4467 |
| Average price | $5.5770 |
| Largest weekly change | +41.8% (Jan 11, 2017) |
| Weeks tracked | 551 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the fluocinolone acetonide, hydroquinone, and tretinoin market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Galderma Laboratories, L.P. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
fluocinolone acetonide, hydroquinone, and tretinoin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TRI-LUMA CREAM?
The current National Average Drug Acquisition Cost (NADAC) for TRI-LUMA CREAM, manufactured by Galderma Laboratories, L.P., is $7.8336 per GM (NDC 00299595030), effective Sep 30, 2026.
How has the price of TRI-LUMA CREAM changed over time?
Over the history we have for it, the NADAC for TRI-LUMA CREAM has risen 143.2%. It has been tracked across 551 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for TRI-LUMA CREAM?
Since Nov 28, 2013, the NADAC for TRI-LUMA CREAM has ranged from a low of $3.2020 (Mar 23, 2016) to a high of $7.8635 (May 14, 2025), with a median of $6.4467 per GM.
Are there cheaper alternatives to TRI-LUMA CREAM?
No other NADAC-published product currently shares the active ingredient and strength of TRI-LUMA CREAM in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TRI-LUMA CREAM?
TRI-LUMA CREAM (NDC 00299595030) is labeled by Galderma Laboratories, L.P., and CMS classifies it as a brand product.